Sitemap
Page 1 of 7 : Next
Posts
- Category: Acne
- Category: AIDS
- Category: Airflow Obstruction
- Role of Endogenous Nitric Oxide in Airflow Obstruction in Smokers (Discussion)
- Role of Endogenous Nitric Oxide in Airflow Obstruction in Smokers (Introduction)
- Role of Endogenous Nitric Oxide in Airflow Obstruction in Smokers (Materials and Methods)
- Role of Endogenous Nitric Oxide in Airflow Obstruction in Smokers (Results)
- Category: Airways
- Category: Aortic Pressure
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: Changes in SAP
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: Conclusion
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: Data Analysis
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: Discussion
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: Effect of Cardiopulmonary Bypass on SAP and LV Area Relations
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: Effect of Open and Closed Chest Conditions
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: LV dysfunction
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: Materials and Methods
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: Outcome
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: Protocol
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: Results
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: Study Limitations
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: TEE
- Determinants of Aortic Pressure Variation During Positive-Pressure Ventilation in Man: Transesophageal Echocardiographic Examination
- Category: Asthma
- Comparison of the Oral and Intravenous Routes for Treating Asthma with Methylprednisolone and Theophylline
- Comparison of the Oral and Intravenous Routes for Treating Asthma with Methylprednisolone and Theophylline: Discussion
- Comparison of the Oral and Intravenous Routes for Treating Asthma with Methylprednisolone and Theophylline: Material and Methods
- Comparison of the Oral and Intravenous Routes for Treating Asthma with Methylprednisolone and Theophylline: Outcome
- Comparison of the Oral and Intravenous Routes for Treating Asthma with Methylprednisolone and Theophylline: Results
- Long-acting asthma medications
- Pulmonary Gas Exchange During Histamine-induced Bronchoconstriction in Asthmatic Subjects
- Pulmonary Gas Exchange During Histamine-induced Bronchoconstriction in Asthmatic Subjects: Conclusion
- Pulmonary Gas Exchange During Histamine-induced Bronchoconstriction in Asthmatic Subjects: Discussion
- Pulmonary Gas Exchange During Histamine-induced Bronchoconstriction in Asthmatic Subjects: Low blood flow
- Pulmonary Gas Exchange During Histamine-induced Bronchoconstriction in Asthmatic Subjects: Methods
- Pulmonary Gas Exchange During Histamine-induced Bronchoconstriction in Asthmatic Subjects: Outcome
- Pulmonary Gas Exchange During Histamine-induced Bronchoconstriction in Asthmatic Subjects: Results
- The MW/FEV, Ratio in Normal and Asthmatic Subjects
- The MW/FEV, Ratio in Normal and Asthmatic Subjects: Asthmatic airways
- The MW/FEV, Ratio in Normal and Asthmatic Subjects: Conclusion
- The MW/FEV, Ratio in Normal and Asthmatic Subjects: Materials and Methods
- The MW/FEV, Ratio in Normal and Asthmatic Subjects: Methacholine Bronchoprovocation Tests
- The MW/FEV, Ratio in Normal and Asthmatic Subjects: Methacholine Studies
- The MW/FEV, Ratio in Normal and Asthmatic Subjects: Outcome
- The MW/FEV, Ratio in Normal and Asthmatic Subjects: Results
- The Spectrum of Irritant-Induced Asthma
- The Spectrum of Irritant-Induced Asthma: Allergic/Atopy
- The Spectrum of Irritant-Induced Asthma: Analysis of Data
- The Spectrum of Irritant-Induced Asthma: Clinical Definitions
- The Spectrum of Irritant-Induced Asthma: Conclusions
- The Spectrum of Irritant-Induced Asthma: Discussion
- The Spectrum of Irritant-Induced Asthma: Medical Evaluation at USF
- The Spectrum of Irritant-Induced Asthma: Results
- The Spectrum of Irritant-Induced Asthma: Time to Onset
- Ventolin during pregnancy: is it dangerous?
- Category: asthma health care
- Category: Birth control
- Category: Blood Gas
- Patterns of Dissimilarities Among Instrument Models in Measuring Po2, Pco2, and pH in Blood Gas Laboratories
- Patterns of Dissimilarities Among Instrument Models in Measuring Po2, Pco2, and pH in Blood Gas Laboratories: Comparisons Within Manufacturers
- Patterns of Dissimilarities Among Instrument Models in Measuring Po2, Pco2, and pH in Blood Gas Laboratories: Conclusion
- Patterns of Dissimilarities Among Instrument Models in Measuring Po2, Pco2, and pH in Blood Gas Laboratories: Materials and Methods
- Patterns of Dissimilarities Among Instrument Models in Measuring Po2, Pco2, and pH in Blood Gas Laboratories: Outcome
- Patterns of Dissimilarities Among Instrument Models in Measuring Po2, Pco2, and pH in Blood Gas Laboratories: Relevance to Blood Measurements
- Patterns of Dissimilarities Among Instrument Models in Measuring Po2, Pco2, and pH in Blood Gas Laboratories: Results
- Patterns of Dissimilarities Among Instrument Models in Measuring Po2, Pco2, and pH in Blood Gas Laboratories: Statistical comparison of the six RAD models
- Patterns of Dissimilarities Among Instrument Models in Measuring Po2, Pco2, and pH in Blood Gas Laboratories: Study
- Patterns of Dissimilarities Among Instrument Models in Measuring Po2, Pco2, and pH in Blood Gas Laboratories: Usefulness of Graphic Displays
- Category: Bronchial Brushing
- Category: Bronchoalveolar Lavage Fluid
- Type 3 Procollagen Peptide in Bronchoalveolar Lavage Fluid
- Type 3 Procollagen Peptide in Bronchoalveolar Lavage Fluid: Clinical Evaluation
- Type 3 Procollagen Peptide in Bronchoalveolar Lavage Fluid: Conclusion
- Type 3 Procollagen Peptide in Bronchoalveolar Lavage Fluid: Corticosteroid Treatment
- Type 3 Procollagen Peptide in Bronchoalveolar Lavage Fluid: Discussion
- Type 3 Procollagen Peptide in Bronchoalveolar Lavage Fluid: Methods
- Type 3 Procollagen Peptide in Bronchoalveolar Lavage Fluid: Pulmonary Function
- Type 3 Procollagen Peptide in Bronchoalveolar Lavage Fluid: Results
- Category: Bullous Emphysema
- An Alternative Technique in the Management of Bullous Emphysema (Discussion)
- An Alternative Technique in the Management of Bullous Emphysema (Introduction)
- An Alternative Technique in the Management of Bullous Emphysema (Materials and Methods)
- An Alternative Technique in the Management of Bullous Emphysema (Results)
- Category: Canadian Health&Care Mall
- Better Online Medicine Shopping Experience Promise Fulfilled
- Canadian Health and Care Mall: Impaired Objective Daytime Vigilance in Obesity-Hypoventilation Syndrome
- Canadian Health&Care Mall about Standards for Training in Endoscopy
- Canadian Health&Care Mall: Mechanical Ventilation
- Canadian Health&Care Mall: Your Life Keeper
- Deliberations of Impaired Objective Daytime Vigilance in Obesity-Hypoventilation Syndrome
- Impaired Objective Daytime Vigilance in Obesity-Hypoventilation Syndrome: Materials and Methods
- Outcomes of Impaired Objective Daytime Vigilance in Obesity-Hypoventilation Syndrome
- Category: Canadian Neighbor Pharmacy
- Category: Cancer
- Angiosarcoma of the of Scalp with Calvarium
- Angiosarcoma of the of Scalp with Calvarium: CASE REPORT
- Angiosarcoma of the of Scalp with Calvarium: DISCUSSION
- Bilateral reduction mammoplasty following breast cancer: A case-control study (part 1)
- Bilateral reduction mammoplasty following breast cancer: A case-control study (part 2)
- Bilateral reduction mammoplasty following breast cancer: A case-control study (part 3)
- Bilateral reduction mammoplasty following breast cancer: A case-control study (part 4)
- Bilateral reduction mammoplasty following breast cancer: A case-control study (part 5)
- Bilateral reduction mammoplasty following breast cancer: A case-control study (part 6)
- Bilateral reduction mammoplasty following breast cancer: A case-control study (part 7)
- Bilateral reduction mammoplasty following breast cancer: A case-control study (part 8)
- Bilateral reduction mammoplasty following breast cancer: A case-control study (part 9)
- Colorectal, Breast, and Prostate Cancers in Medicaid
- Colorectal, Breast, and Prostate Cancers in Medicaid: DISCUSSION
- Colorectal, Breast, and Prostate Cancers in Medicaid: DISCUSSION part 2
- Colorectal, Breast, and Prostate Cancers in Medicaid: METHODS
- Colorectal, Breast, and Prostate Cancers in Medicaid: RESULTS
- Mammography Use
- Mammography Use: DISCUSSION
- Mammography Use: METHODS
- Mammography Use: RESULTS
- Mammography Use: STATISTICAL ANALYSIS Major
- Paler Is Better, Say Skin Cancer Fighters (part 1)
- Paler Is Better, Say Skin Cancer Fighters (part 2)
- Paler Is Better, Say Skin Cancer Fighters (part 3)
- Paler Is Better, Say Skin Cancer Fighters (part 4)
- Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease
- Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease: HORMONE REPLACEMENT THERAPY
- Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease: The PEPI Trial
- Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease: The WHI Trial
- RADIATION MEDICINE INNOVATIONS FOR THE NEW MILLENIUM
- RADIATION MEDICINE INNOVATIONS FOR THE NEW MILLENIUM: INTENSITY-MODULATED RADIATION THERAPY
- RADIATION MEDICINE INNOVATIONS FOR THE NEW MILLENIUM: STEREOTACTIC RADIOSURGERY
- RADIATION MEDICINE INNOVATIONS FOR THE NEW MILLENIUM: ULTRASOUND-GUIDED TRANSPERINEAL
- Unusual Moles Play Leading Role in New Strategies for Predicting and Preventing Malignant Melanoma (part 1)
- Unusual Moles Play Leading Role in New Strategies for Predicting and Preventing Malignant Melanoma (part 2)
- Unusual Moles Play Leading Role in New Strategies for Predicting and Preventing Malignant Melanoma (part 3)
- Unusual Moles Play Leading Role in New Strategies for Predicting and Preventing Malignant Melanoma (part 4)
- Category: Carcinoma
- Category: Cardiac Performance
- Category: Cardiac Transplant
- The Cardiopulmonary Response to OKT3 in Orthotopic Cardiac Transplant Recipients
- The Cardiopulmonary Response to OKT3 in Orthotopic Cardiac Transplant Recipients: Conclusion
- The Cardiopulmonary Response to OKT3 in Orthotopic Cardiac Transplant Recipients: Discussion
- The Cardiopulmonary Response to OKT3 in Orthotopic Cardiac Transplant Recipients: Materials and Methods
- The Cardiopulmonary Response to OKT3 in Orthotopic Cardiac Transplant Recipients: Outcome
- The Cardiopulmonary Response to OKT3 in Orthotopic Cardiac Transplant Recipients: Results
- Category: Cardiology
- Effects of the antiarrhythmic agent tedisamil on cardiac potassium currents in humans (part 1)
- Effects of the antiarrhythmic agent tedisamil on cardiac potassium currents in humans (part 10). DISCUSSION
- Effects of the antiarrhythmic agent tedisamil on cardiac potassium currents in humans (part 11). DISCUSSION
- Effects of the antiarrhythmic agent tedisamil on cardiac potassium currents in humans (part 12). CONCLUSION
- Effects of the antiarrhythmic agent tedisamil on cardiac potassium currents in humans (part 2). MATERIALS AND METHODS
- Effects of the antiarrhythmic agent tedisamil on cardiac potassium currents in humans (part 3). MATERIALS AND METHODS
- Effects of the antiarrhythmic agent tedisamil on cardiac potassium currents in humans (part 4). RESULTS
- Effects of the antiarrhythmic agent tedisamil on cardiac potassium currents in humans (part 5). RESULTS
- Effects of the antiarrhythmic agent tedisamil on cardiac potassium currents in humans (part 6). RESULTS
- Effects of the antiarrhythmic agent tedisamil on cardiac potassium currents in humans (part 7). RESULTS
- Effects of the antiarrhythmic agent tedisamil on cardiac potassium currents in humans (part 8). RESULTS
- Effects of the antiarrhythmic agent tedisamil on cardiac potassium currents in humans (part 9). RESULTS
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 1)
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 10)
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 11).
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 12).
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 13)
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 2). ANIMALS AND METHODS
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 3)
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 4)
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 5)
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 6). RESULTS
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 7) / purchase Tavist
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 8). DISCUSSION
- Participation of nitric oxide in regional coronary bloodflow regulation during myocardial ischemia in the canine heart (part 9)
- Category: chest pain
- Category: Cipro
- Category: Cough
Plugin by dagondesign.com